Si-bone Share Price (NASDAQ: SIBN)

$16.68

▲

0.06

(0.36%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Si-bone Stock chart to analyse performance

Si-bone stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$16.57
Today's High:$16.82
$16.68
0.66%
Downside
Day's Volatility :1.49%
Upside
0.83%
52 Weeks Low:$11.70
52 Weeks High:$20.05
$16.68
29.86%
Downside
52 Weeks Volatility :41.65%
Upside
16.81%

Si-bone Stock Returns

Period	Si-bone Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-11.69%	3.6%	0.0%
6 Months	-5.21%	-7.7%	0.0%
1 Year	4.49%	-12.6%	0.0%
3 Years	0.39%	9.5%	-4.7%

Si-bone Inc Key Stats

Check Si-bone key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$16.62
Open	$16.57
Today's High	$16.82
Today's Low	$16.57
Market Capitalization	$719.2M
Today's Volume	$197.4K
52 Week High	$20.05
52 Week Low	$11.7
Revenue TTM	$185.3M
EBITDA	$-22.7M
Earnings Per Share (EPS)	$-0.57
Profit Margin	-12.83%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-14.18%

Stock Returns calculator for Si-bone Stock including INR - Dollar returns

The Si-bone stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Si-bone investment value today

Current value as on today

₹1,09,927

Returns

₹9,927

(+9.93%)

Returns from Si-bone Stock

₹4,642 (+4.64%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Si-bone Stock

100%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Si-bone Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Si-bone Inc

Name
Holdings %
Name
Holdings %
BlackRock Inc
8.64%
Orbimed Advisors, LLC
7.98%
Brown Advisory Holdings Inc
6.75%
Vanguard Group Inc
5.68%
American Century Companies Inc
5.37%
Champlain Investment Partners, LLC
4.96%

Analyst Recommendation on Si-bone Stock

Rating

Trend

Buy

93%Buy

6%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Si-bone(by analysts ranked 0 to 5 stars)

Si-bone Share Price Target

What analysts predicted

Upside of 49.88%

Target:

$25.00

Current:

$16.68

Si-bone share price target is $25.00, a slight Upside of 49.88% compared to current price of $16.68 as per analysts' prediction.

Si-bone Stock Insights

Price Movement
In the last 3 months, SIBN stock has moved down by -11.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 47.29M → 48.63M (in $), with an average increase of 2.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -6.54M → -6.15M (in $), with an average increase of 6.3% per quarter
SIBN vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 28.8%
SIBN vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 162.1%
Price to Sales
ForSIBN every $1 of sales, investors are willing to pay $3.8, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Si-bone Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$67.3M	↑ 21.53%
Net Income	$-42.6M	↑ 143.95%
Net Profit Margin	-63.26%	↓ 31.75%

	FY20	Y/Y Change
Revenue	$73.4M	↑ 9.04%
Net Income	$-48.5M	↑ 14.01%
Net Profit Margin	-66.15%	↓ 2.89%

	FY21	Y/Y Change
Revenue	$90.2M	↑ 22.84%
Net Income	$-60.1M	↑ 23.87%
Net Profit Margin	-66.7%	↓ 0.55%

	FY22	Y/Y Change
Revenue	$106.4M	↑ 18.03%
Net Income	$-62.9M	↑ 4.62%
Net Profit Margin	-59.11%	↑ 7.59%

	FY23	Y/Y Change
Revenue	$138.9M	↑ 30.52%
Net Income	$-43.3M	↓ 31.11%
Net Profit Margin	-31.2%	↑ 27.91%

	FY24	Y/Y Change
Revenue	$167.2M	↑ 20.37%
Net Income	$-30.9M	↓ 28.67%
Net Profit Margin	-18.49%	↑ 12.71%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$37.9M	↓ 2.55%
Net Income	$-10.9M	↓ 0.72%
Net Profit Margin	-28.8%	↓ 0.54%

	Q2 FY24	Q/Q Change
Revenue	$40.0M	↑ 5.55%
Net Income	$-8.9M	↓ 18.02%
Net Profit Margin	-22.36%	↑ 6.44%

	Q3 FY24	Q/Q Change
Revenue	$40.3M	↑ 0.93%
Net Income	$-6.6M	↓ 26.45%
Net Profit Margin	-16.3%	↑ 6.06%

	Q4 FY24	Q/Q Change
Revenue	$49.0M	↑ 21.47%
Net Income	$-4.5M	↓ 31.63%
Net Profit Margin	-9.17%	↑ 7.13%

	Q1 FY25	Q/Q Change
Revenue	$47.3M	↓ 3.49%
Net Income	$-6.5M	↑ 45.54%
Net Profit Margin	-13.83%	↓ 4.66%

	Q2 FY25	Q/Q Change
Revenue	$48.6M	↑ 2.83%
Net Income	$-6.2M	↓ 5.96%
Net Profit Margin	-12.65%	↑ 1.18%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$60.5M	↑ 19.71%

	FY20	Y/Y Change
Profit	$64.5M	↑ 6.57%

	FY21	Y/Y Change
Profit	$79.7M	↑ 23.63%

	FY22	Y/Y Change
Profit	$90.7M	↑ 13.77%

	FY23	Y/Y Change
Profit	$109.4M	↑ 20.63%

	FY24	Y/Y Change
Profit	$132.1M	↑ 20.75%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$29.9M	↑ 4.15%

	Q2 FY24	Q/Q Change
Profit	$31.6M	↑ 5.73%

	Q3 FY24	Q/Q Change
Profit	$31.9M	↑ 1.04%

	Q4 FY24	Q/Q Change
Profit	$38.8M	↑ 21.55%

	Q1 FY25	Q/Q Change
Profit	$37.7M	↓ 2.79%

	Q2 FY25	Q/Q Change
Profit	$38.8M	↑ 2.95%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-31.6M	↑ 117.83%
Investing Cash Flow	$13.5M	↓ 113.79%
Financing Cash Flow	$3.5M	↓ 96.97%

	FY20	Y/Y Change
Operating Cash Flow	$-30.7M	↓ 3.05%
Investing Cash Flow	$-62.9M	↓ 566.36%
Financing Cash Flow	$136.4M	↑ 3810.58%

	FY21	Y/Y Change
Operating Cash Flow	$-39.5M	↑ 28.93%
Investing Cash Flow	$51.6M	↓ 181.98%
Financing Cash Flow	$-1.7M	↓ 101.25%

	FY22	Y/Y Change
Operating Cash Flow	$-41.7M	↑ 5.37%
Investing Cash Flow	$-2.8M	↓ 105.46%
Financing Cash Flow	$2.2M	↓ 228.4%

	FY23	Y/Y Change
Operating Cash Flow	$-18.7M	↓ 55.08%
Investing Cash Flow	$-59.8M	↑ 2024.26%
Financing Cash Flow	$90.9M	↑ 4038.96%

	FY24	Y/Y Change
Operating Cash Flow	$-12.4M	↓ 33.6%
Investing Cash Flow	$12.6M	↓ 121.11%
Financing Cash Flow	$2.0M	↓ 97.85%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-7.6M	↑ 229.6%
Investing Cash Flow	$6.3M	↓ 133.56%
Financing Cash Flow	$105.0K	↓ 87.53%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-6.3M	↓ 16.34%
Investing Cash Flow	$-1.8M	↓ 128.83%
Financing Cash Flow	$1.8M	↑ 1591.43%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$302.0K	↓ 104.77%
Investing Cash Flow	$3.8M	↓ 305.96%
Financing Cash Flow	$155.0K	↓ 91.27%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$1.2M	↑ 290.07%
Investing Cash Flow	$4.3M	↑ 15.07%
Financing Cash Flow	$-78.0K	↓ 150.32%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-4.9M	↓ 516.89%
Investing Cash Flow	$10.6M	↑ 145.1%
Financing Cash Flow	$103.0K	↓ 232.05%

Si-bone Technicals Summary

Sell

Neutral

Buy

Si-bone is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Si-bone Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Si-bone Inc	-4.23%	-5.21%	4.49%	0.39%	-24.67%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Si-bone Inc	NA	NA	NA	-0.59	-0.14	-0.08	NA	3.96
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Si-bone Inc	Buy	$719.2M	-24.67%	NA	-12.83%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Si-bone Inc

SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated design; iFuse TORQ, a line of 3D-printed threaded implants designed for applications in pelvic trauma and sacroliliac fusion; and iFuse Bedrock Granite Implant System that provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion; and iFuse TORQ TNT to treat pelvic trauma and sacroiliac joint dysfunction, as well as iFuse INTRA implants that are marketed as human cells, tissues, and cellular or tissue-based products. The company markets its products primarily with a direct sales force, as well as through third-party sales agent and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Organization	Si-bone
Employees	349
CEO	Ms. Laura A. Francis MBA
Industry	Health Technology

Key Management of Si-bone Inc

Name	Title
Mr. Jeffrey W. Dunn	Executive Chairman
Ms. Laura A. Francis MBA	CEO & Director
Mr. Anshul Maheshwari	Chief Financial Officer
Mr. Anthony J. Recupero	President of Commercial Operations
Dr. Scott A. Yerby Ph.D.	Senior VP of Engineering & CTO
Saqib Iqbal	Director of FP&A and Investor Relations
Mr. Michael A. Pisetsky J.D.	Chief Business & Legal Affairs Officer, Secretary and General Counsel
Mr. Nikolas F. Kerr	Senior Vice President of Product, Marketing & Business Development
Ms. Aimee Einstein	Vice President of People & Culture
Dr. Daniel Joseph Cher M.D.	Senior Vice President of Clinical & Regulatory Affairs

Important FAQs about investing in SIBN Stock from India :

What is Si-bone share price today?

Si-bone share price today is $16.68 as on August 30, 2025 at 1:29 am IST at the close of the market. Si-bone share today touched a day high of $16.82 and a low of $16.57.

What is the 52 week high and 52 week low for Si-bone share?

Si-bone share touched a 52 week high of $20.05 and a 52 week low of $11.70. Si-bone stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $16.68, lower by 16.81% versus the 52 week high.

How to invest in Si-bone Stock (SIBN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Si-bone on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Si-bone Shares that will get you 0.0899 shares as per Si-bone share price of $16.68 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Si-bone Stock (SIBN) from India?

Indian investors can start investing in Si-bone (SIBN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Si-bone stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Si-bone share’s latest price of $16.68 as on August 30, 2025 at 1:29 am IST, you will get 0.5995 shares of Si-bone. Learn more about fractional shares .

What are the returns that Si-bone has given to Indian investors in the last 5 years?

Si-bone stock has given -24.67% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?